DRW Securities’s Arcadia Biosciences RKDA Stock Holding History

DRW Securities’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,032	Closed	-$34.8K	–	1621
2025 Q3	$34.8K	Buy	+10,032	New	+$41K	﹤0.01%	1239

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

DRW Securities's RKDA Position: Q4 2025 in Review

DRW Securities sold out of Arcadia Biosciences (RKDA) in Q4 2025, closing a stake of 10,032 shares — an estimated $34.8K sold.

DRW Securities first reported a position in RKDA in Q3 2025 and held it in 1 quarter. The position peaked at $34.8K in Q3 2025. 13 funds tracked by Wall St. Rank hold RKDA as of Q4 2025.

DRW Securities reported no remaining Arcadia Biosciences position as of Q4 2025 after selling out during the quarter.
DRW Securities sold 10,032 Arcadia Biosciences shares in Q4 2025, an estimated $34.8K.
DRW Securities first reported a position in Arcadia Biosciences in Q3 2025 and held it in 1 quarter.
DRW Securities's Arcadia Biosciences position peaked at $34.8K in Q3 2025.
13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.